121 related articles for article (PubMed ID: 18552727)
1. Stepping into the wide world.
Anderson D
Sci Pract Perspect; 2004 Aug; 2(2):3. PubMed ID: 18552727
[No Abstract] [Full Text] [Related]
2. Community treatment programs take up buprenorphine.
Casadonte PP; Kolodner GF; Horton T; McMurphy SM
Sci Pract Perspect; 2004 Aug; 2(2):24-9. PubMed ID: 18552729
[TBL] [Abstract][Full Text] [Related]
3. Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis.
Van Zee A; Fiellin DA
Am J Public Health; 2019 Mar; 109(3):393-394. PubMed ID: 30726142
[No Abstract] [Full Text] [Related]
4. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island.
Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L
Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657
[No Abstract] [Full Text] [Related]
5. Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programs.
Friedmann PD; Jiang L; Alexander JA
J Behav Health Serv Res; 2010 Jul; 37(3):322-37. PubMed ID: 19296223
[TBL] [Abstract][Full Text] [Related]
6. Maintenance buprenorphine for opioid users.
Law FD; Nutt DJ
Lancet; 2003 Feb; 361(9358):634-5. PubMed ID: 12606172
[No Abstract] [Full Text] [Related]
7. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
Cottrill CB; Matson SC
Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
[No Abstract] [Full Text] [Related]
8. Coordination of medical care and opioid dependence treatment in primary care: a case report.
Fiellin DA; Rosenheck RA; Kosten TR
Subst Abus; 2003 Mar; 24(1):43-6. PubMed ID: 12652094
[No Abstract] [Full Text] [Related]
9. Integration of buprenorphine for substance-abuse treatment by HIV care providers.
Friedland G; Vlahov D
J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1():S1-2. PubMed ID: 21317588
[No Abstract] [Full Text] [Related]
10. Substance abuse treatment organizations as mediators of social policy: slowing the adoption of a congressionally approved medication.
Wallack SS; Thomas CP; Martin TC; Chilingerian J; Reif S
J Behav Health Serv Res; 2010 Jan; 37(1):64-78. PubMed ID: 18668369
[TBL] [Abstract][Full Text] [Related]
11. Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
Yang JC; Roman-Urrestarazu A; Brayne C
PLoS One; 2020; 15(3):e0229787. PubMed ID: 32126120
[TBL] [Abstract][Full Text] [Related]
12. Behavioural treatment combined with buprenorphine does not reduce opioid use compared with buprenorphine alone.
Weiss RD
Evid Based Ment Health; 2014 May; 17(2):e2. PubMed ID: 24591547
[No Abstract] [Full Text] [Related]
13. Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.
Savage SA; Abraham AJ; Knudsen HK; Rothrauff TC; Roman PM
J Subst Abuse Treat; 2012 Jan; 42(1):16-24. PubMed ID: 21831565
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine: blending practice and research.
Ling W; Smith D
J Subst Abuse Treat; 2002 Sep; 23(2):87-92. PubMed ID: 12220606
[TBL] [Abstract][Full Text] [Related]
15. Agency offers guidance on office-based drug treatment for opioid addiction.
Mitka M
JAMA; 2003 Feb; 289(6):690. PubMed ID: 12585931
[No Abstract] [Full Text] [Related]
16. Perioperative Management and Analgesia for Patients Taking Buprenorphine and Other Forms of Medication-Assisted Treatment for Substance Abuse Disorders.
Scholzen E; Zeng AM; Schroeder KM
Adv Anesth; 2019 Dec; 37():65-86. PubMed ID: 31677660
[No Abstract] [Full Text] [Related]
17. Development and implementation of an opioid overdose prevention program within a preexisting substance use disorders treatment center.
Wilder CM; Brason FW; Clark AK; Galanter M; Walley AY; Winstanley EL
J Addict Med; 2014; 8(3):164-9. PubMed ID: 24874760
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine: a new treatment for opioid addiction.
Harv Ment Health Lett; 2001 Feb; 17(8):6-7. PubMed ID: 11175458
[No Abstract] [Full Text] [Related]
19. Initial strategies for integrating buprenorphine into HIV care settings in the United States.
Sullivan LE; Bruce RD; Haltiwanger D; Lucas GM; Eldred L; Finkelstein R; Fiellin DA
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S191-6. PubMed ID: 17109306
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine prescribing by APRNs.
Rundio A
J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
